Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
- 1 August 1992
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 142 (2), 128-130
- https://doi.org/10.1016/0304-3940(92)90355-b
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Deprenyl suppresses the oxidant stress associated with increased dopamine turnoverAnnals of Neurology, 1989
- The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's DiseaseScience, 1989
- Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian BrainsJournal of Neurochemistry, 1989
- Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatmentNeuroscience Letters, 1986
- Detection of 5-S-cysteinyldopamine in human brainJournal of Neural Transmission, 1985
- Glutathione peroxidase activity in Parkinson's disease brainNeuroscience Letters, 1985
- Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm studyJournal of Neural Transmission, 1985
- FREE AMINO ACIDS AND RELATED COMPOUNDS IN BIOPSIES OF HUMAN BRAINJournal of Neurochemistry, 1971
- Individual Comparisons by Ranking MethodsBiometrics Bulletin, 1945